Roswell Park selects Circuit Clinical as collaborator for CIMAvax clinical trial

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Circuit Clinical announced a collaboration with Roswell Park Comprehensive Cancer Center to support the expansion of clinical trial opportunities to its outpatient oncology practices. This collaboration marks Circuit Clinical’s entry into oncology clinical research, with both digital and clinical services.

Circuit Clinical will be delivering both research operational support and TrialScout– its patient experience platform– in support of Roswell Park’s groundbreaking CIMAvax-EGF Clinical Trial.

Circuit Clinical will be providing patient identification, engagement, enrollment and ongoing patient experience support services under the direction of the Roswell Park Comprehensive Cancer Center clinical research leadership team.

In addition to its main campus on Carlton Street in the City of Buffalo, Roswell Park offers care at satellite offices in Amherst and Niagara Falls and at five affiliated community practices.

Through this collaboration, eligible patients with certain forms of lung and head/neck cancer will have the opportunity to participate in the CIMAvax Clinical Trial onsite at one or more of the following practices:

  • Roswell Park Jamestown Medical Oncology & Hematology,

  • Roswell Park Hematology Oncology of Niagara,

  • Roswell Park Hematology Oncology Southtowns,

  • Roswell Park Hematology Oncology Northtowns.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login